STERIS Stock Forecast for 2023 - 2025 - 2030
Updated on 04/18/2024
STERIS Stock Forecast and Price Target
The average price target for STERIS's stock lately set by several renowned analysts is $238.01, which would result in a potential upside of approximately 18.52% if it reaches this mark by December 31, 2024. This estimation is based on a high estimate of $265.00 and a low estimate of $215.00. If you want to buy STE stock, it might be a good idea to look at its competitors too.
18.52% Upside
STERIS Fair Value Forecast for 2023 - 2025 - 2030
In the last five years, STERIS has seen a decline in its Price, from $145.68 to $0.00 – a 100.00% decrease. For the next year, analysts are expecting Fair Value to reach $270.18 – an increase of 100.00%. Over the next six years, experts predict that Fair Value will grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| AAPL Stock Forecast | Apple | Outperform |
16
|
$167.04 | Buy/Sell | $200.65 | 19.73% |
| AMZN Stock Forecast | Amazon.com Inc | Buy |
13
|
$179.22 | Buy/Sell | $204.68 | 18.85% |
| A005930 Stock Forecast | Samsung Electronics | Outperform |
10
|
₩79.60k | Buy/Sell | ₩92.49k | 25.63% |
| JNJ Stock Forecast | Johnson & Johnson | Outperform |
9
|
$145.74 | Buy/Sell | $174.55 | 16.65% |
| ABT Stock Forecast | Abbott Laboratories | Outperform |
9
|
$105.27 | Buy/Sell | $118.92 | 20.64% |
STERIS Revenue Forecast for 2023 - 2025 - 2030
In the last three years, STERIS's Revenue has grown by 63.58%, from $3.03B to $4.96B. For the next year, analysts are expecting Revenue to reach $5.85B – an increase of 18.00%. Over the next six years, experts predict that Revenue will grow by 65.45%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| DHR Stock Forecast | Danaher | Outperform |
10
|
$236.36 | Buy/Sell | $260.33 | 14.23% |
| GE Stock Forecast | General Electric | Outperform |
8
|
$152.94 | Buy/Sell | $144.00 | 10.17% |
| NKE Stock Forecast | NIKE Inc | Outperform |
16
|
$95.74 | Buy/Sell | $123.50 | 20.64% |
.jpg)
STERIS Dividend per Share Forecast for 2023 - 2025 - 2030
In the last three years, STERIS's Dividend per Share has grown from $1.45 to $1.84 – a 26.90% increase. Next year, analysts are expecting Dividend per Share to reach $2.04 – an increase of 10.87%. Over the next six years, the forecast is for Dividend per Share to grow by 5.91%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ISRG Stock Forecast | Intuitive Surgical | Outperform |
13
|
$372.63 | Buy/Sell | $408.45 | 15.40% |
| SYK Stock Forecast | Stryker Corp | Outperform |
10
|
$327.45 | Buy/Sell | $353.16 | 11.93% |
| MDT Stock Forecast | Medtronic | Outperform |
11
|
$79.19 | Buy/Sell | $92.47 | 20.60% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BSX Stock Forecast | Boston Scientific | Outperform |
11
|
$67.42 | Buy/Sell | $70.14 | 8.28% |
| BDX Stock Forecast | Becton Dickinson and Co | Outperform |
9
|
$233.15 | Buy/Sell | $284.47 | 20.09% |
| ECL Stock Forecast | Ecolab | Hold |
18
|
$219.21 | Buy/Sell | $205.36 | 5.38% |
STERIS EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, STERIS's EBITDA has grown by 79.81%, rising from $743.18M to $1.34B. For next year, analysts predict EBITDA of $2.07B, which would mean an increase of 55.09%. Over the next six years, experts predict that STERIS's EBITDA will grow at a rate of 25.54%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| EW Stock Forecast | Edwards Lifesciences Corp | Outperform |
11
|
$86.45 | Buy/Sell | $91.18 | 12.20% |
| MMM Stock Forecast | 3M | Hold |
10
|
$91.48 | Buy/Sell | $109.39 | 9.31% |
| KMB Stock Forecast | Kimberly-Clark | Hold |
18
|
$125.61 | Buy/Sell | $128.04 | 6.68% |
STERIS EBIT Forecast for 2023 - 2025 - 2030
In the last three years, STERIS's EBIT has grown, rising from $545.94M to $783.43M – a growth of 43.50%. In the next year, analysts believe that EBIT will reach $1.41B – an increase of 80.48%. For the next six years, the forecast is for EBIT to grow by 59.41%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| IDXX Stock Forecast | IDEXX Laboratories | Outperform |
14
|
$477.79 | Buy/Sell | $583.92 | 25.58% |
| RKT Stock Forecast | Reckitt Benckiser Group | Outperform |
12
|
£41.39 | Buy/Sell | £66.68 | 38.92% |
| FTV Stock Forecast | Fortive | Outperform |
18
|
$80.18 | Buy/Sell | $86.47 | 13.49% |
STERIS EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last five years, STERIS has seen a decline in its EPS, from $5.64 to $0.00 – a 100.00% decrease. For the next year, analysts are expecting EPS to reach $10.46 – an increase of 100.00%. Over the next six years, experts predict that EPS will grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| GRMN Stock Forecast | Garmin | Hold |
18
|
$140.72 | Buy/Sell | $128.46 | -0.51% |
| CAH Stock Forecast | Cardinal Health Inc | Hold |
13
|
$106.00 | Buy/Sell | $108.07 | 8.96% |
| MTD Stock Forecast | Mettler-Toledo International | Hold |
13
|
$1.19k | Buy/Sell | $1.12k | 3.14% |
.jpg)